Drug Database
Back to search

France· FR:63631908

AKLIEF 50 microgrammes/g, crème

A trifarotene product, registered in France by GALDERMA INTERNATIONAL. The same ATC class is registered in 15 of our 19 countries.

ATC D10AD06

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedAKLIEF 50 microgrammes/g, crèmeATCD10AD06REGISTER NO.FR:63631908PACKS LISTED2CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about AKLIEFAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Trifarotene is registered in 15 of 19 countries.

Countries holding a registration under ATC D10AD06 (trifarotene), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose
Search trifarotene products by name

Trifarotene · ATC D10AD06

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Manufacturer
GALDERMA INTERNATIONAL
Country
France (FR)
ATC code
D10AD06
ATC class
Trifarotene
Defined daily dose
50 mcg, T
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

  • cip13
    3400930202197
    1 flacon(s) pompe multidose(s) polypropylène polyéthylène haute densité (PEHD) de 30 g
  • cip13
    3400930202203
    1 flacon(s) pompe multidose(s) polypropylène polyéthylène haute densité (PEHD) de 75 g

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

9 interactions on record for trifarotene.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check trifarotene against other medicinesHow interaction checks work

Trifarotene · interactions on record

9 records

  • 1 severe
  • 8 moderate

Most severe, free to view

  • Aminolevulinic acidL01XD04severe
  • Salicylic acidD01AE12moderate
  • IsotretinoinD10AD04moderate
  • Benzoyl peroxideD10AE01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Trifarotene in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All trifarotene products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Belgium · Aklief
  • Bulgaria · Аклиеф
  • Cyprus · Selgamis
  • Czechia · Aklief
  • Germany · Selgamis
  • Denmark · Aklief
  • Estonia · Aklief
  • Spain · Aklief
  • Finland · Aklief
  • United Kingdom (Northern Ireland) · Aklief
  • Greece · Selgamis
  • Croatia · Aklief
  • Hungary · Aklief
  • Ireland · Aklief
  • Iceland · Aklief
  • Italy · Selgamis
  • Lithuania · Aklief
  • Luxembourg · Aklief
  • Latvia · Aklief
  • Malta · Aklief
  • Netherlands · Aklief
  • Norway · Aklief
  • Poland · Aklief
  • Portugal · Aklief
  • Romania · Aklief
  • Sweden · Aklief
  • Slovakia · Aklief

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4fbab98b-f9b3-4778-b135-fdc884b04d9f
GET /v1/drugs/4fbab98b-f9b3-4778-b135-fdc884b04d9f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "63631908",
  "date_amm": "2020-02-17",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "crème",
  "voies_administration": "cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Oui"
}
API referenceMCP serverPlans

See everything about trifarotene.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console